News
5 minute read

McDonnell Boehnen Hulbert & Berghoff LLP a Proud Sponsor of 2014 BIO IP & Diagnostics Symposium

McDonnell Boehnen Hulbert & Berghoff LLP is proud to be an official sponsor of the 2014 BIO IP & Diagnostics Symposium set for September 26, 2014 in Alexandria, VA. MBHB partners Dr. Kevin Noonan and Dr. Donald Zuhn, Jr. are set to participate as featured presenters.

Session 1 (8:15-9:30 a.m.): Squaring the Circle: Obtaining Patents That Are Valid, Commercially Meaningful, and Enforceable

Sponsored by: McDonnell Boehnen Hulbert & Berghoff LLP

The panel will discuss strategies for obtaining patent protection for natural product drugs and diagnostic methods, in view of recent Supreme Court cases and how those cases are interpreted by lower courts and the PTO. Specifically, the panelists will discuss the PTO Guidances interpreting the Mayo and Myriad cases, and the consequences that will result depending on how broadly this precedent is applied.

Moderator:

  • Donald Zuhn, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP

Panelists:

  • Sherry Knowles, Principal, Knowles IP Strategies
  • Kevin Noonan, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP

About the BIO IP & Diagnostics Symposium

BIO’s IP & Diagnostics Symposium (BIO IPDX) will review the current patent law landscape and evaluate the impact on both the genetic diagnostics and biopharmaceutical sectors. The program will review IP issues for both diagnostics generally and companion diagnostics. The program will also explore some of the potential regulatory dimensions. BIO aims to use this event to inform industry and government alike on how to move the science forward in the current climate.

View registration details here